Bosutinib reduces endothelial permeability and organ failure in a rat polytrauma transfusion model
Open Access
- 5 March 2021
- journal article
- research article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 126 (5) , 958-966
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2015
- Vascular endothelial growth factor receptor tyrosine kinase inhibitors versus bevacizumab in metastatic colorectal cancer: A systematic review and meta-analysisMolecular and Clinical Oncology, 2015
- Targeting Abl Kinases to Regulate Vascular Leak During Sepsis and Acute Respiratory Distress SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2015
- Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe TraumaJAMA, 2015
- Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2015
- The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinasesBiochemical Journal, 2015
- Micro-osmotic pumps for continuous release of the tyrosine kinase inhibitor bosutinib in juvenile rats and its impact on bone growthMedical Science Monitor Basic Research, 2013
- Acute Coagulopathy of Trauma in the RatShock, 2013
- Effective Treatment of Edema and Endothelial Barrier Dysfunction With ImatinibCirculation, 2012
- Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failureBlood, 2012